W. Edward Craighead
J. Rex Fuqua Endowed Chair; Professor and Vice Chair of the Child, Adolescent, and Young Adult Programs; Department of Psychiatry and Behavioral Sciences
Dr. Craighead is a Professor and the Vice Chair of the Department of Psychiatry and Behavioral Sciences at Emory. His research largely focuses on cognitive behavioral models for major depression and bipolar disorders.
Dr. W. Edward Craighead is the J. Rex Fuqua Endowed Chair; Director and Vice Chair of Child, Adolescent, and Young Adult Programs; and a professor in the Department of Psychiatry and Behavioral Sciences at Emory University. Dr. Craighead has 50 years of experience in the youth mental health field. He rose through the academic ranks and has several major publications on bipolar disorder and major depressive disorder.
Dr. Craighead’s research, which focuses on mood disorders such as depression and bipolar disorder, is focused on investigating patterns of neural connectivity and the genetic markers to better predict the success of various therapy models including cognitive behavior therapy and medication. His work also focuses on the prevention of the first episode of depression.
Dr. Craighead his wife, Linda Craighead, and his colleague, Dr. David Miklowitz, recently published the third edition of their graduate level Psychopathology book.
Education and Training
Abilene Christian College (1965)
University of Illinois Urbana-Champaign (1967)
University of Illinois Urbana-Champaign (1970)
The Pennsylvania State University, Duke University, University of Colorado – Boulder, Emory University
“AIM has begun at a critical time in the promotion of mental health and well-being among youth. There is a national shortage in youth mental health providers, at the same time we are making tremendous progress in understanding, preventing, and treating problems in youth mental health. Implementation of the mission of AIM will facilitate the training of providers in evidence-based treatment while providing support for creative and collaborative clinical research that will allow the field to advance especially in the development of treatments for the most complicated disorders that have resisted standard interventions. AIM’s support of this creative and novel clinical work is critical.”W. Edward CraigheadEmory University